Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02283216
Other study ID # 1409M53708
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date June 1, 2015
Est. completion date September 13, 2017

Study information

Verified date April 2019
Source University of Minnesota - Clinical and Translational Science Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate different stimulation parameters for a new noninvasive approach for modulating the brain that could potentially be beneficial for decreasing tinnitus perception. The new approach is called Multimodal Synchronization Therapy (mSync). mSync uses a combination of acoustic stimulation played through headphones and low levels of electrical current delivered via electrodes placed on the surface of different body regions. The timing interval between the acoustic and body stimulation is varied in order to cause different types of changes in the brain. In addition to acoustic and body stimulation, noninvasive cortical stimulation will also be presented as part of mSync to attempt to further modulate or decrease the tinnitus percept. Cortical stimulation will be performed by placing a magnetic coil over a spot on the head and sending a brief magnetic pulse that can travel through the skin and bone to create electrical current inside the head. For this study, different body locations as well as specific timing intervals among acoustic, body, and cortical stimulation will be investigated to identify appropriate parameters that can modulate and potentially decrease tinnitus perception. Different mSync parameters will be investigated across multiple testing sessions (up to 16 weekly sessions) and the tinnitus percept will be closely monitored throughout the study.


Description:

This study is not specifically seeking to treat tinnitus but is designed to investigate various mSync parameters that can alter the tinnitus percept. Findings from this study will help identify specific mSync parameters that can be more effective at decreasing or fully suppressing the tinnitus percept that will be systematically explored in a follow-up study.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date September 13, 2017
Est. primary completion date September 13, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Have subjective, non-pulsatile, and bothersome tinnitus

- Will not start any new tinnitus treatment during the study

- Ability to give informed consent and understand study objectives in English

- Willing and able to understand and comply with all study-related procedures

Exclusion Criteria:

- Substantial hearing loss or hyperacusis that may interfere with the study

- Medical history of other ear or brain disorders, history of seizures, or currently using any medication or treatments that can cause or increase the chances of seizures

- Any implanted medical or metal device, such as a pacemaker, aneurysm clip, or cochlear implant

- Pregnant or currently breast-feeding (we need to give all female subjects a pregnancy test because pregnant females and unborn children need extra protection for their safety)

- Any handicap that prevents the subject from reliably performing the tests

Study Design


Related Conditions & MeSH terms


Intervention

Device:
noise sound stimulation (Tucker-Davis Technologies)
Band-limited white noise stimulus, comfortable loudness level, presented via headphones or earphones with Tucker-Davis Technologies device.
body electrical stimulation (Digitimer device)
Single pulse electrical stimulation on different body regions, comfortable current level, presented via surface pads or clips with Digitimer device.
transcranial magnetic stimulation (Magstim)
Single pulse magnetic stimulation over frontal cortex, comfortable level at 110% resting motor threshold, presented via magnetic coil with Magstim device.

Locations

Country Name City State
United States Nils Hasselmo Hall, 6-105 Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota - Clinical and Translational Science Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Tinnitus Functional Index Questionnaire Score A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score. Change from baseline score at 1 week after testing paradigm
Primary Change in Minimal Masking Level A narrowband noise (from 2-12 kHz) is presented to the tinnitus ear and the minimum sound level (in decibel sound pressure level, decibel SPL) is determined that completely masks the tinnitus percept. Change in baseline level at an expected average of 1 minute and 1.5 hours after testing paradigm
Secondary Change in Tinnitus Handicap Inventory Questionnaire Score A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score. Change from baseline score at 1 week after testing paradigm
Secondary Change in Tinnitus Rating (0-10, 10 being worst) The subject rates the disturbance or bothering nature of the tinnitus. Change in baseline rating at an expected average of 4 minutes and 1.5 hours after testing paradigm
Secondary Change in Tinnitus Subjective Description The subject describes the quality, characteristics and bothering nature of the tinnitus. Change in baseline description at an expected average of 5 minutes and 1.5 hours after testing paradigm
Secondary Change in Tinnitus Matching (pitch and loudness) The subject adjusts the loudness and pitch (i.e., frequency) of a sound played to an ear to that of the tinnitus percept. Change in baseline pitch and loudness at an expected average of 1.5 hours after testing paradigm
Secondary Daily Tinnitus Journal Entries The subject describes the quality, characteristics and bothering nature of the tinnitus on a daily basis. The subject can also include any unusual or interesting events relating to the tinnitus that he/she feels would be relevant for the study. 0, 1, 2, 3, 4, 5, 6, 7 days post-testing paradigm
See also
  Status Clinical Trial Phase
Recruiting NCT05963542 - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia N/A
Recruiting NCT04987502 - Virtual Reality and Subjective Tinnitus N/A
Recruiting NCT04404439 - Treatment of Tinnitus With Migraine Medications Phase 4
Recruiting NCT05533840 - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Completed NCT03552302 - Effects of Yoga Exercise on Participates With Tinnitus
Enrolling by invitation NCT02617953 - Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus N/A
Completed NCT02269839 - A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus N/A
Completed NCT02974543 - Somatosensory Stimulation to Alleviate Tinnitus N/A
Withdrawn NCT01663467 - Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy N/A
Completed NCT01929837 - Tinnitus rTMS 2013 N/A
Completed NCT01857661 - The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial N/A
Completed NCT01927991 - Internet-based Self-help for Tinnitus: The Role of Support N/A
Completed NCT01480193 - New Therapy for Patients With Severe Tinnitus N/A
Terminated NCT01412918 - Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression N/A
Completed NCT00371436 - Progressive Intervention Program for Tinnitus Management N/A
Completed NCT00748475 - Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus N/A
Completed NCT00733044 - Cost-effectiveness of Multidisciplinary Management of Tinnitus N/A
Active, not recruiting NCT05518682 - Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus N/A
Recruiting NCT05212298 - Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus N/A
Completed NCT06025097 - Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus. Early Phase 1